Mechanisms of vascular angiotensin II surface receptor regulation by epidermal growth factor

Journal of Cellular Physiology

Volumn 200, Issue 3, 2004, Pages 451-457

  Ullian, Michael E ^a,b   Webb, Jerry G ^a   Chen, Ruihua ^a   Paul, Richard V ^a   Morinelli, Thomas A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR; CALMODULIN INHIBITOR; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLOHEXIMIDE; CYTOCHALASIN D; DACTINOMYCIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; INOSITOL PHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHOTRANSFERASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN SYNTHESIS INHIBITOR;

ANIMAL CELL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CELL CULTURE; CYTOSKELETON; ENZYME INHIBITION; IMMUNOBLOTTING; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; RAT; RAT STRAIN; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; CELLS, CULTURED; CYTOCHALASIN D; DACTINOMYCIN; DOWN-REGULATION; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; LIGANDS; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ANGIOTENSIN; TYRPHOSTINS;

EID: 3442899027     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20027     Document Type: Article

References (27)

1. Ball RL, Tanner KD, Carpenter G. 1990. Epidermal growth factor potentiates cyclic AMP accumulation in A-431 cells. J Biol Chem 265:12836-12845.
2. Budnik LT, Mukhopadhyay AK. 1991. Epidermal growth factor, a modulator of luteal adenylate cyclase. J Biol Chem 266:13908-13913.
3. Chen X, Nishimura J, Hasna J, Kobayashi S, Shikasho T, Kanaide H. 1994. Protein kinase C and protein kinase A regulate the expression of angiotensin II receptor mRNA in smooth muscle cells. Eur J Pharmacol 267:175-183.
4. Chen Z, Nield HS, Sun H, Barbier A, Patel TB. 1995. Expression of type V adenylyl cyclase is required for epidermal growth factor-mediated stimulation of cAMP accumulation. J Biol Chem 270:27525-27530.
5. Crowley ST, Ray CJ, Nawaz D, Majack RA, Horwitz LD. 1995. Multiple growth factors are released from mechanically injured vascular smooth muscle cells. Am J Physiol 269:H1641-H1647.
6. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, Inagami T. 1998. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273:8890-8896.
7. Fricke K, Wirthensohn K, Laxhuber R, Sackmann E. 1986. Flicker spectroscopy of erythrocytes. Eur Biophys J 14:67-81.
8. Hayry P, Myllarniemi M, Aavik E, Alatalo S, Aho P, Yilmaz S, Raisanen-Sokolowski A, Cozzone G, Jameson BA, Baserga R. 1995. Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat. FASEB J 9:1336-1344.
9. Hubbard CJ. 1994. EGF modulates phosphoinositide levels in ovarian granulosa cells stimulated by luteinizing hormone. J Cell Physiol 160:227-232.
10. 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol 139:279-293.
11. Kubalak SW, Webb JG. 1993. Angiotensin II enhancement of hormone-stimulated cAMP formation in cultured vascular smooth muscle cells. Am J Physiol 264:H86-H96.
12. Levitzki A, Gazit A. 1995. Tyrosine kinase inhibition: An approach to drug development. Science 267:1782-1788.
13. Li X, Lee JW, Graves LM, Earp HS. 1998. Angiotensin II stimulates ERK via two pathways in epithelial cells: Protein kinase C suppresses a G-protein coupled receptor-EGF receptor transactivation pathway. EMBO J 17:2574-2583.
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
15. Meijerman I, Blom WM, deBont HJGM, Mulder GJ, Nagelkerke JF. 1999. Induction of apoptosis and changes in nuclear G-actin are mediated by different pathways: The effect of inhibitors of protein and RNA synthesis in isolated rat hepatocytes. Toxicol Appl Pharmacol 156:46-55.
16. Miyagawa J, Higashiyama S, Kawata S, Yoshiaki I, Tamura S, Yamamoto K, Nishida M, Nakamura T, Yamashita S, Matsuzawa Y, Taniguchi N. 1995. Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J Clin Invest 95:404-411.
17. 2+/calmodulin-dependent transactivation of epidermal growth factor receptor. Circ Res 82:1338-1348.
18. Nickenig G, Murphy TJ. 1994. Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression. Mol Pharmacol 46:653-659.
19. Sato A, Suzuki H, Murakami M, Nakazato Y, Iwaita Y, Saruta T. 1994. Glucocorticoid increases angiotensin II type 1 receptor and its gene expression. Hypertension 23:25-30.
20. Sinha BK, Chignell CF. 1979. Interaction of antitumor drugs with human erythrocyte ghost membranes and mastocytoma P 815: A spin label study. Biochem Biophys Res Commun 86:1051-1057.
21. Ullian ME, Fine JJ. 1994. Mechanisms of enhanced angiotensin II-stimulated signal transduction in vascular smooth muscle by aldosterone. J Cell Physiol 161:201-208.
22. Ullian ME, Linas SL. 1990. Angiotensin II surface receptor coupling to inositol trisphosphate formation in vascular smooth muscle cells. J Biol Chem 265:195-200.
23. Ullian ME, Walsh LG. 1995. Corticosterone metabolism and effects on angiotensin II receptors in vascular smooth muscle. Circ Res 77:702-709.
24. Ullian ME, Schelling JR, Linas SL. 1992. Aldosterone enhances angiotensin II receptor binding and mositol phosphate responses. Hypertension 20:67-73.
25. Ullian ME, Hutchison FN, Hazen-Martin DJ, Morinelli TA. 1993. Angiotensin II-aldosterone interactions on protein synthesis in vascular smooth muscle cells. Am J Physiol 264:C1525-C1531.
26. Ullian ME, Raymond JR, Willingham MC, Paul RV. 1997. Regulation of vascular angiotensin II receptors by EGF. Am J Physiol 273:C1241-C1249.
27. Ushio-Fukai M, Hilenski L, Santanam N, Becker PL, Ma Y, Griendling KK, Alexander RW. 2001. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells. J Biol Chem 276:48269-48275.